Edwards expands its Every Heartbeat Matters initiative


Edwards life sciences graphicEdwards Lifesciences has announced a new goal for its philanthropic initiative, Every Heartbeat Matters (EHM), which aims to improve the lives of 2.5 million additional underserved structural heart and critical care patients by the end of 2025. The company says that, as part of the next phase, EHM will also establish an enhanced product donation programme that provides its partners with access to donated Edwards products to provide humanitarian treatment for underserved patients outside of the USA.

The next phase of EHM will broaden its focus from heart valve disease to all structural heart diseases and critical care support. Additionally, a company press release states, EHM will invest in programmes impacting each stage of the patient journey, from detection to treatment, with an additional emphasis on recovery. Edwards says that, since it launched in 2014, the EHM community of more than 60 partners has educated, screened and treated more than 1.7 million underserved people, surpassing the initial goal of one million by 2020, and the expanded programme is based on accumulated knowledge and experience over the past six years on how to have the greatest impact on patients.

The press release also points out that, globally, there are millions of structural heart and critical care patients who face socioeconomic disparities that limit awareness and access to care. With the strength and support of the EHM partner community, the initiative aims to make a difference for patients facing these challenges.

Amanda Fowler, executive director, Edwards Lifesciences Foundation, says: “The global impact that Every Heartbeat Matters has created over the past six years to help underserved people was possible because of the dedication of our charitable partners and employees. We are committed to doing even more with the next phase of EHM and are particularly excited about our enhanced product donation programme, which is a direct response to the feedback from our dedicated partners.”

Edwards Lifesciences Foundation will soon be accepting requests for funding from non-profit organisations to partner on programmes for the EHM initiative, or those that strengthen the communities where Edwards employees live and work. The 2020 grant cycle is open from 11 May to 26 June.


Please enter your comment!
Please enter your name here